Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Affymetrix, Inc.    AFFX

SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 

Affymetrix, Inc. : Affymetrix to Host Conference Call on May 3, 2012 to Announce First Quarter 2012 Operating Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 10:20pm CEST

Affymetrix, Inc. (NASDAQ: AFFX) today announced that its first quarter 2012 operating results will be reported after market close on Thursday May 3, 2012. The company will also hold a conference call on the same day at 5:00pm ET.

A live webcast can be accessed by visiting the investor relations section of the company's website at www.affymetrix.com. Alternatively, investors and other interested parties may listen to the live conference call by dialing 877-407-8291 (domestic) or 201-689-8345 (international).

A replay of this call will be available from 5:00pm PT on May 3, 2012 until 8:00pm PT on May 10, 2012 at the following numbers: 877-660-6853 (domestic), 201-612-7415 (international). The conference identification number for the replay is 392482. An archived webcast of the conference call will be available under the investor relations section of the company's website at www.affymetrix.com.

About Affymetrix

Affymetrix technology is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes. More than 2,000 systems have been shipped globally and approximately 25,000 peer-reviewed papers have been published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Santa Clara, Cleveland, Ohio, and Singapore. The company has about 900 employees worldwide and maintains sales and distribution operations across Europe, Asia, and Latin America. For more information about Affymetrix, please visit www.affymetrix.com.

Affymetrix, Inc.
Investor:
Doug Farrell, 408-731-5285
Vice President, Investor Relations


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AFFYMETRIX, INC.
2016 AFFYMETRIX : Receives a Hold from Cantor Fitzgerald (Cantor Bryan Brokmeier Comm..
2016 AFFYMETRIX : Grant Supports Outcomes Research for Noninvasive Genomic Profiling
2016 AFFYMETRIX : Entry into a Material Definitive Agreement, Termination of a Materi..
2016 AFFYMETRIX : Determines Unsolicited Proposal from Origin Technologies Could Lead..
2016DJTHERMO FISHER SCIENTIFIC : Completes Acquisition of Affymetrix
2016DJTHERMO FISHER SCIENTIFIC : Completes Acquisition of Affymetrix
2016 AFFYMETRIX : Origin Significantly Enhances All-Cash Offer for Affymetrix
2016 AFFYMETRIX : Former Affymetrix Senior Executives Propose to Acquire Affymetrix f..
2016 AFFYMETRIX : Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit A..
2016 THERMO FISHER SCIENTIFIC : Affymetrix Reaffirms Support For Thermo Fisher Merger..
More news
Sector news : Bio Diagnostics & Testing
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
More sector news : Bio Diagnostics & Testing
News from SeekingAlpha
2016 WEEK IN REVIEW : Deals Dominate China Biopharma News
2016 IBM Buys Salesforce.com Cloud Consultant
2016 30% Annual Return From This Stock
2016 *Except For Amazon
2016 WALL STREET BREAKFAST : Yellen Speech Takes Center Stage
Advertisement
Chart AFFYMETRIX, INC.
Duration : Period :
Affymetrix, Inc. Technical Analysis Chart | AFFX | US00826T1088 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Seth H. Hoogasian Chief Executive Officer & Secretary
Robert H. Trice Independent Director
Gary S. Guthart Director
David A. Weber Chief Commercial Officer
Kim Caple Senior Vice President & GM-Clinical Business
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AFFYMETRIX, INC.0.00%0
MIRACA HOLDINGS INC.-0.95%2 757
BEIJING STRONG BIOTECH..--.--%1 439
GENSCRIPT BIOTECH CORP22.16%945
SEEGENE INC--.--%759
INNATE PHARMA-22.93%655
More Results